DE69828390D1 - Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung - Google Patents

Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung

Info

Publication number
DE69828390D1
DE69828390D1 DE69828390T DE69828390T DE69828390D1 DE 69828390 D1 DE69828390 D1 DE 69828390D1 DE 69828390 T DE69828390 T DE 69828390T DE 69828390 T DE69828390 T DE 69828390T DE 69828390 D1 DE69828390 D1 DE 69828390D1
Authority
DE
Germany
Prior art keywords
composition
diaminotrifluoromethylpyrimidin
anticreasic
derivatives
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69828390T
Other languages
English (en)
Other versions
DE69828390T2 (de
Inventor
Yoshifumi Ogura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Application granted granted Critical
Publication of DE69828390D1 publication Critical patent/DE69828390D1/de
Publication of DE69828390T2 publication Critical patent/DE69828390T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69828390T 1997-02-28 1998-02-26 Antikrebs-zusammensetzung Expired - Lifetime DE69828390T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6008397 1997-02-28
JP6008397 1997-02-28
PCT/JP1998/000776 WO1998037887A1 (en) 1997-02-28 1998-02-26 Anticancer composition comprising a diaminotrifluoromethylpyridine derivative

Publications (2)

Publication Number Publication Date
DE69828390D1 true DE69828390D1 (de) 2005-02-03
DE69828390T2 DE69828390T2 (de) 2005-06-02

Family

ID=13131845

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69828390T Expired - Lifetime DE69828390T2 (de) 1997-02-28 1998-02-26 Antikrebs-zusammensetzung

Country Status (11)

Country Link
US (1) US6197796B1 (de)
EP (1) EP0971711B1 (de)
KR (1) KR20000075769A (de)
CN (1) CN1111407C (de)
AT (1) ATE285771T1 (de)
AU (1) AU731274B2 (de)
CA (1) CA2280744A1 (de)
DE (1) DE69828390T2 (de)
TW (1) TW415843B (de)
WO (1) WO1998037887A1 (de)
ZA (1) ZA981430B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653333B2 (en) 2000-01-31 2003-11-25 Ishihara Sangyo Kaisha, Ltd. Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives
AU2001228862A1 (en) * 2000-02-01 2001-08-14 Ishihara Sangyo Kaisha Ltd. Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
JP4848092B2 (ja) 2000-02-01 2011-12-28 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤
EP1557670A4 (de) * 2002-10-30 2007-03-07 Ishihara Sangyo Kaisha Regulation der wechselwirkung zwischenrapl und rap1
CN103183813A (zh) 2005-04-22 2013-07-03 三菱化学株式会社 来自生物质资源的聚酯及其制造方法
DE102008015424A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit Menthoxypropandiol
JP5584518B2 (ja) 2009-05-28 2014-09-03 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤
TW202110800A (zh) 2019-05-15 2021-03-16 日商石原產業股份有限公司 Ｎ－（２－乙基磺醯基胺基－５－三氟甲基－３－吡啶基）環己烷羧醯胺．一鈉鹽之無水合物結晶體

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69127595T2 (de) * 1990-07-10 1998-01-22 Ishihara Sangyo Kaisha Diaminotrifluoromethylpyrimidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Phospholipase-A2-Inhibitoren
ZA915023B (en) * 1990-07-10 1992-05-27 Ishihara Sangyo Kaisha Diaminotrifluoromethylpyridine derivatives,process for their production and phospholipase a2 inhibitor containing them

Also Published As

Publication number Publication date
ATE285771T1 (de) 2005-01-15
AU731274B2 (en) 2001-03-29
EP0971711B1 (de) 2004-12-29
DE69828390T2 (de) 2005-06-02
ZA981430B (en) 1998-08-24
AU6116398A (en) 1998-09-18
EP0971711A1 (de) 2000-01-19
CA2280744A1 (en) 1998-09-03
US6197796B1 (en) 2001-03-06
CN1111407C (zh) 2003-06-18
CN1248166A (zh) 2000-03-22
TW415843B (en) 2000-12-21
WO1998037887A1 (en) 1998-09-03
KR20000075769A (ko) 2000-12-26

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE223378T1 (de) Prolineamid-derivate
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
DE68924681T2 (de) Heterocyclische Biphosphonsäurederivate.
AU2002213421A1 (en) Condensed pyridoindole derivatives
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
TR200001452T2 (tr) Bifenilamidin türevleri.
NO923721D0 (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
TW354762B (en) Agent for prophylaxis or treatment of cataract
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
EP0842663A4 (de) Ophtalmika
DE69330601T2 (de) Serotoninergische ergolin derivate
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
CA2195031A1 (en) Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition